Page 2 - Jb Chemicals & Pharmaceuticals

JB Chemicals surges 11%, hits new high on report of PE firms eyeing stake

In the past one month, the stock rallied 39 per cent against 15 per cent rise in the S&P BSE Sensex

JB Chemicals surges 31% in eight days; stock nears record high

On April 1, the SC set aside the NGT order directing revocation of environmental clearance and closure of the company's bulk drugs Unit at Panoli, Gujarat

JB Chemicals nears record high in weak market, rebounds 8% from day's low

In the past three months, JB Chemicals & Pharma has outpaced the market by surging 48 per cent against 7.8 per cent decline in the S&P BSE Sensex

JB Chemicals gains 7% as board mulls share buyback plan

The stock of JB Chemicals has underperformed the market since it touched its recent high of Rs 405 on September 13, 2019.

USFDA wraps up inspection of JB Chemicals Panoli unit with no observations

JB Chemicals & Pharmaceuticals Wednesday said the US health regulator has concluded inspection of its manufacturing facility at Panoli in Gujarat without any observations. The US Food and Drug Administration (USFDA) has concluded inspection of company's newly set-up and commissioned solid oral dosage forms formulations manufacturing facility at Panoli, Gujarat, JB Chemicals & Pharmaceuticals said in a BSE filing. "At the end of inspection, no objectionable observations were found and hence no form 483 was issued," it stated. The said inspection was carried out from June 24-28, 2019, the company said. A Form 483, is issued by the USFDA to notify a company's management of any objectionable condition at its manufacturing facility. The form is issued after completing the inspection. JB Chemicals & Pharmaceuticals said this facility has capacity of two billion tablets per annum, which is expandable to nine billion tablets per annum. The company said new facility will augment ...

JB Chemicals surges 12% as board mulls share buyback proposal

The stock rallied 12% to Rs 338 on the BSE in intra-day trade after the company announced that its board will meet on August 31, to consider a share buyback proposal.

JB Chemicals & Pharmaceuticals Q1 net up 26% at Rs 49.85 crore

Shares of JB Chemicals & Pharmaceuticals were trading at Rs 346.70 per scrip on BSE

JB Chemicals hit lifetime high post Q1 results

The stock surged 14% to Rs 357, also its lifetime high on the BSE, on back of heavy volumes.

JB Chemicals surges on USFDA approval for Panoli tablet manufacturing facility

The stock rallied 11% to Rs 261 on the BSE on back of heavy volumes.